Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia

Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia

US Patent 10828377 · Granted Nov 10, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for evaluating multiple different genes of interest2023
Pharmaceutical composition for treating FLT3 mutation-positive cancer, mutant FL2018
Pharmaceutical composition for treating FLT3 mutation-positive cancer, mutant FL2018
EML4-ALK fusion gene2018
Detection method for novel ROS1 fusions2015
EML4-ALK fusion gene2015
Identification, assessment, and therapy of cancers with innate or acquired resis2015
CD20 negatively converted B-cell malignant lymphoma cell line and utilization th2013
Method for screening candidate compounds for antitumor drug2013
Method for screening candidate compounds for antitumor drug2013
Di(arylamino)aryl compounds2012
EML4-ALK fusion gene2012